Evidence map›Paper›PMID 41394231›Full record

ArticleCureus2025

Association Between the Ki-67 Index, Tumor Size and Postoperative Structural Persistence in Non-functioning Pituitary Neuroendocrine Tumors: A Single-Center Experience.

Carlos E Jimenez-Canizales, Juan S Salas-Henao, Gabriela Ballesteros-Oviedo, Rafael Parra-Medina, Edgar G Ordóñez-Rubiano, Johan E Vargas-Vargas, William Rojas

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlos E Jimenez-CanizalesEndocrinology, University Foundation for Health Sciences, Bogotá, COL.
Juan S Salas-HenaoEndocrinology, University Foundation for Health Sciences, Bogotá, COL.
Gabriela Ballesteros-OviedoEndocrinology, University Foundation for Health Sciences, Bogotá, COL.
Rafael Parra-MedinaPathology, Instituto Nacional de Cancerología, Bogotá, COL.
Edgar G Ordóñez-RubianoNeurosurgery, University Foundation for Health Sciences, Bogotá, COL.
Johan E Vargas-VargasFamily Medicine, University Foundation for Health Sciences, Bogotá, COL.
William RojasEndocrinology, Hospital de San José, Bogotá, COL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Non-functioning pituitary neuroendocrine tumors (NF-PitNETs) represent more than half of pituitary neoplasms. Features linked to greater aggressiveness include adrenocorticotropic hormone immunopositivity, plurihormonal or null-cell phenotype, elevated Ki-67 index (≥3%), and size ≥40 mm. However, evidence remains inconsistent, underscoring the need for further investigation into their biological behavior. Methods A retrospective study of medical records of patients with diagnoses related to pituitary pathology from 2010 to 2020 was conducted. The primary objective of this study was to evaluate the association between the Ki-67 proliferation index and tumor size with post-surgical structural persistence in patients with NF-PitNETs. The sample consisted of 81 patients who met the inclusion criteria. Clinical and paraclinical characteristics were recorded. The data were analyzed using univariate description and bivariate analysis, applying Fisher's test for the outcome of post-surgical structural persistence. Results The prevalence of NF-PitNETs was 58%. The most frequent symptoms were visual field disorders in 70%, followed by headache in 66%. Regarding structural persistence, a statistical association was found between the presence of Ki-67 ≥ 3% (p-value: 0.028) and tumor size ≥ 40 mm (p-value: 0.030). Conclusion The prevalence of NF-PitNETs is high, and the preoperative variable of tumor size (≥ 40 mm) and the Ki-67% index ≥ 3% reported in postoperative pathology were associated with greater structural persistence.

Indexed as

ki-67 antigenlocoregional neoplasm recurrencenonfunctioning adenomapitnets pituitary neoplasmstreatment outcome

Identifiers

PMID41394231
PMCPMC12698381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.